You just read:

Nordic Nanovector Completes Patient Enrolment Into Phase 1 Trial of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL)

News provided by

Nordic Nanovector

11 Jul, 2019, 14:03 BST